• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表达克里米亚-刚果出血热病毒核蛋白的基于DNA的辛德毕斯复制子的免疫原性

Immunogenicity of a DNA-Based Sindbis Replicon Expressing Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein.

作者信息

Tipih Thomas, Heise Mark, Burt Felicity Jane

机构信息

Division of Virology, University of the Free State, Bloemfontein 9300, South Africa.

Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

出版信息

Vaccines (Basel). 2021 Dec 16;9(12):1491. doi: 10.3390/vaccines9121491.

DOI:10.3390/vaccines9121491
PMID:34960237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8703447/
Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV) infrequently causes hemorrhagic fever in humans with a case fatality rate of 30%. Currently, there is neither an internationally approved antiviral drug nor a vaccine against the virus. A replicon based on the Sindbis virus vector encoding the complete open reading frame of a CCHFV nucleoprotein from a South African isolate was prepared and investigated as a possible candidate vaccine. The transcription of CCHFV RNA and recombinant protein production by the replicon were characterized in transfected baby hamster kidney cells. A replicon encoding CCHFV nucleoprotein inserted in plasmid DNA, pSinCCHF-52S, directed transcription of CCHFV RNA in the transfected cells. NIH-III heterozygous mice immunized with pSinCCHF-52S generated CCHFV IgG specific antibodies with notably higher levels of IgG2a compared to IgG1. Splenocytes from mice immunized with pSinCCHF-52S secreted IFN-γ and IL-2, low levels of IL-6 or IL-10, and no IL-4. No specific cytokine production was registered in splenocytes of mock-immunized mice ( < 0.05). Thus, our study demonstrated the expression of CCHFV nucleoprotein by a Sindbis virus vector and its immunogenicity in mice. The spectrum of cytokine production and antibody profile indicated predominantly Th1-type of an anti-CCHFV immune response. Further studies in CCHFV-susceptible animals are necessary to determine whether the induced immune response is protective.

摘要

克里米亚-刚果出血热病毒(CCHFV)极少导致人类出血热,病死率为30%。目前,既没有国际上批准的抗病毒药物,也没有针对该病毒的疫苗。制备了一种基于辛德毕斯病毒载体的复制子,其编码来自南非分离株的CCHFV核蛋白的完整开放阅读框,并作为一种可能的候选疫苗进行了研究。在转染的幼仓鼠肾细胞中对该复制子的CCHFV RNA转录和重组蛋白产生进行了表征。插入质粒DNA(pSinCCHF-52S)中的编码CCHFV核蛋白的复制子在转染细胞中指导CCHFV RNA的转录。用pSinCCHF-52S免疫的NIH-III杂合小鼠产生了CCHFV IgG特异性抗体,与IgG1相比,IgG2a水平显著更高。用pSinCCHF-52S免疫的小鼠的脾细胞分泌IFN-γ和IL-2,IL-6或IL-10水平较低,且不分泌IL-4。在 mock免疫小鼠的脾细胞中未检测到特异性细胞因子产生(<0.05)。因此,我们的研究证明了辛德毕斯病毒载体表达CCHFV核蛋白及其在小鼠中的免疫原性。细胞因子产生谱和抗体谱表明主要是抗CCHFV免疫反应的Th1型。有必要在对CCHFV易感的动物中进行进一步研究,以确定诱导的免疫反应是否具有保护性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994b/8703447/673951d9f58f/vaccines-09-01491-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994b/8703447/ce13a69dcc86/vaccines-09-01491-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994b/8703447/a53cd856d96b/vaccines-09-01491-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994b/8703447/b78da76c6a89/vaccines-09-01491-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994b/8703447/673951d9f58f/vaccines-09-01491-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994b/8703447/ce13a69dcc86/vaccines-09-01491-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994b/8703447/a53cd856d96b/vaccines-09-01491-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994b/8703447/b78da76c6a89/vaccines-09-01491-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994b/8703447/673951d9f58f/vaccines-09-01491-g004.jpg

相似文献

1
Immunogenicity of a DNA-Based Sindbis Replicon Expressing Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein.表达克里米亚-刚果出血热病毒核蛋白的基于DNA的辛德毕斯复制子的免疫原性
Vaccines (Basel). 2021 Dec 16;9(12):1491. doi: 10.3390/vaccines9121491.
2
Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.用编码克里米亚-刚果出血热病毒衣壳蛋白和包膜蛋白的DNA质粒及/或病毒样颗粒进行免疫可诱导受攻击小鼠产生保护作用并使其存活。
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.02076-16. Print 2017 May 15.
3
Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge.复制型 RNA 疫苗接种会引发一种意想不到的免疫反应,能有效地保护小鼠免受克里米亚-刚果出血热病毒的致死性挑战。
EBioMedicine. 2022 Aug;82:104188. doi: 10.1016/j.ebiom.2022.104188. Epub 2022 Jul 27.
4
Enhanced Seroconversion to West Nile Virus Proteins in Mice by West Nile Kunjin Replicon Virus-like Particles Expressing Glycoproteins from Crimean-Congo Hemorrhagic Fever Virus.通过表达来自克里米亚-刚果出血热病毒糖蛋白的西尼罗库京复制子病毒样颗粒增强小鼠对西尼罗病毒蛋白的血清转化
Pathogens. 2022 Feb 10;11(2):233. doi: 10.3390/pathogens11020233.
5
Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.评价细胞培养基和小鼠脑来源的克里米亚-刚果出血热病毒灭活疫苗在短暂免疫抑制(IS)小鼠模型中的效果。
PLoS Negl Trop Dis. 2020 Nov 23;14(11):e0008834. doi: 10.1371/journal.pntd.0008834. eCollection 2020 Nov.
6
Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice Models.牛疱疹病毒 4 型(BoHV-4)载体递送克里米亚-刚果出血热病毒核衣壳蛋白可诱导 IFNα/β/γR-/- 小鼠模型产生相当的保护性免疫,以抵抗致死性挑战。
Viruses. 2019 Mar 9;11(3):237. doi: 10.3390/v11030237.
7
A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.一种用于克里米亚-刚果出血热的DNA疫苗在两种致死性小鼠模型中可预防疾病和死亡。
PLoS Negl Trop Dis. 2017 Sep 18;11(9):e0005908. doi: 10.1371/journal.pntd.0005908. eCollection 2017 Sep.
8
A structure-based virtual screening and molecular docking by using potent inhibitors against nucleoprotein of .基于结构的虚拟筛选和分子对接,使用有效的抑制剂针对 核蛋白。
J Vector Borne Dis. 2021 Apr-Jun;58(2):126-134. doi: 10.4103/0972-9062.321757.
9
Co-Delivery Effect of CD24 on the Immunogenicity and Lethal Challenge Protection of a DNA Vector Expressing Nucleocapsid Protein of Crimean Congo Hemorrhagic Fever Virus.载 CD24 对表达克里米亚-刚果出血热病毒核衣壳蛋白的 DNA 载体的免疫原性和致死性攻毒保护的共递送效应。
Viruses. 2019 Jan 17;11(1):75. doi: 10.3390/v11010075.
10
Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)-Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests.采用重组克里米亚-刚果出血热病毒核蛋白作为抗原,通过 μ 捕获和 IgG 免疫复合物(IC)ELISA 试验,对人血清中克里米亚-刚果出血热病毒(CCHFV)特异性 IgM 和 IgG 抗体进行敏感和特异性检测。
PLoS Negl Trop Dis. 2018 Mar 26;12(3):e0006366. doi: 10.1371/journal.pntd.0006366. eCollection 2018 Mar.

引用本文的文献

1
Crimean-Congo haemorrhagic fever (CCHF): present and future therapeutic armamentarium.克里米亚-刚果出血热(CCHF):当前及未来的治疗手段
Infez Med. 2024 Dec 1;32(4):421-433. doi: 10.53854/liim-3204-2. eCollection 2024.
2
The Role of Nucleocapsid Protein (NP) in the Immunology of Crimean-Congo Hemorrhagic Fever Virus (CCHFV).核衣壳蛋白(NP)在克里米亚-刚果出血热病毒(CCHFV)免疫学中的作用。
Viruses. 2024 Sep 30;16(10):1547. doi: 10.3390/v16101547.
3
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.

本文引用的文献

1
Epidemiological Aspects of Crimean-Congo Hemorrhagic Fever in Western Europe: What about the Future?西欧克里米亚-刚果出血热的流行病学现状:未来如何?
Microorganisms. 2021 Mar 21;9(3):649. doi: 10.3390/microorganisms9030649.
2
Purification of Crimean-Congo hemorrhagic fever virus nucleoprotein and its utility for serological diagnosis.克里米亚-刚果出血热病毒核蛋白的纯化及其在血清学诊断中的应用。
Sci Rep. 2021 Jan 27;11(1):2324. doi: 10.1038/s41598-021-81752-0.
3
A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model.
新发和再发传染病:全球趋势及预防和控制新策略。
Signal Transduct Target Ther. 2024 Sep 11;9(1):223. doi: 10.1038/s41392-024-01917-x.
4
Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 subunit vaccine combination prevents morbidity in mice.克里米亚-刚果出血热病毒核蛋白与GP38亚单位疫苗组合可预防小鼠发病。
NPJ Vaccines. 2024 Aug 14;9(1):148. doi: 10.1038/s41541-024-00931-y.
5
Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Diagnosis, Clinical Management, and Therapeutics.克里米亚-刚果出血热病毒临床医师诊疗手册:诊断、临床管理和治疗。
Emerg Infect Dis. 2024 May;30(5):864-873. doi: 10.3201/eid3005.231648.
6
Crimean-Congo Hemorrhagic Fever Virus: Progress in Vaccine Development.克里米亚-刚果出血热病毒:疫苗研发进展
Diagnostics (Basel). 2023 Aug 19;13(16):2708. doi: 10.3390/diagnostics13162708.
7
Advances and perspectives in the development of vaccines against highly pathogenic bunyaviruses.高致病性布尼亚病毒疫苗研发的进展与展望。
Front Cell Infect Microbiol. 2023 May 18;13:1174030. doi: 10.3389/fcimb.2023.1174030. eCollection 2023.
8
Crimean-Congo haemorrhagic fever virus.克里米亚-刚果出血热病毒。
Nat Rev Microbiol. 2023 Jul;21(7):463-477. doi: 10.1038/s41579-023-00871-9. Epub 2023 Mar 14.
9
Perspective Technologies of Vaccination: Do We Still Need Old Vaccines?疫苗接种的前沿技术:我们仍需要传统疫苗吗?
Vaccines (Basel). 2022 Jun 2;10(6):891. doi: 10.3390/vaccines10060891.
一种基于 DNA 的疫苗可预防食蟹猕猴模型中的克里米亚-刚果出血热病毒病。
Nat Microbiol. 2021 Feb;6(2):187-195. doi: 10.1038/s41564-020-00815-6. Epub 2020 Nov 30.
4
The interplays between Crimean-Congo hemorrhagic fever virus (CCHFV) M segment-encoded accessory proteins and structural proteins promote virus assembly and infectivity.克里米亚-刚果出血热病毒(CCHFV)M 节编码的辅助蛋白与结构蛋白之间的相互作用促进了病毒的组装和感染力。
PLoS Pathog. 2020 Sep 21;16(9):e1008850. doi: 10.1371/journal.ppat.1008850. eCollection 2020 Sep.
5
Crimean-Congo Hemorrhagic Fever Virus: Advances in Vaccine Development.克里米亚-刚果出血热病毒:疫苗研发进展
Biores Open Access. 2020 May 12;9(1):137-150. doi: 10.1089/biores.2019.0057. eCollection 2020.
6
Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever.基于水疱性口炎病毒的疫苗可保护小鼠免受克里米亚-刚果出血热的侵害。
Sci Rep. 2019 May 23;9(1):7755. doi: 10.1038/s41598-019-44210-6.
7
Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice Models.牛疱疹病毒 4 型(BoHV-4)载体递送克里米亚-刚果出血热病毒核衣壳蛋白可诱导 IFNα/β/γR-/- 小鼠模型产生相当的保护性免疫,以抵抗致死性挑战。
Viruses. 2019 Mar 9;11(3):237. doi: 10.3390/v11030237.
8
Plasmid DNA-based Alphavirus Vaccines.基于质粒DNA的甲病毒疫苗。
Vaccines (Basel). 2019 Mar 8;7(1):29. doi: 10.3390/vaccines7010029.
9
Co-Delivery Effect of CD24 on the Immunogenicity and Lethal Challenge Protection of a DNA Vector Expressing Nucleocapsid Protein of Crimean Congo Hemorrhagic Fever Virus.载 CD24 对表达克里米亚-刚果出血热病毒核衣壳蛋白的 DNA 载体的免疫原性和致死性攻毒保护的共递送效应。
Viruses. 2019 Jan 17;11(1):75. doi: 10.3390/v11010075.
10
Mapping of B-cell epitopes on the N- terminal and C-terminal segment of nucleocapsid protein from Crimean-Congo hemorrhagic fever virus.克-雅氏病病毒核衣壳蛋白 N 端和 C 端片段 B 细胞表位的定位。
PLoS One. 2018 Sep 20;13(9):e0204264. doi: 10.1371/journal.pone.0204264. eCollection 2018.